InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025)
InMed Pharmaceuticals' (INM) quarterly Raw Materials came in at $172200.0 in Q3 2025, down 37.26% year-on-year from $274445.0 in Q3 2024, and down 33.33% quarter-over-quarter from $258300.0 in Q2 2025.
InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Raw Materials history runs 4 years deep, the most recent figure standing at $172200.0 for Q3 2025.
- On a quarterly basis, Raw Materials fell 37.26% year-over-year to $172200.0 in Q3 2025; TTM through Sep 2025 was $172200.0, a 37.26% decrease from a year earlier, with the FY2025 full-year figure at $258300.0, down 30.69% from the prior year.
- Raw Materials declined to $172200.0 in Q3 2025 per INM's latest filing, from $258300.0 in the prior quarter.
- Across five years, Raw Materials topped out at $387071.0 in Q1 2023 and bottomed at $172200.0 in Q4 2024.
- The 4-year median for Raw Materials is $233518.5 (2022), against an average of $250874.9.
- Biggest YoY gain for Raw Materials was 78.55% in 2024; the steepest drop was 49.23% in 2024.
- Year by year, Raw Materials stood at $208737.0 in 2022, then changed by 0.0% to $208737.0 in 2023, then slipped by 17.5% to $172200.0 in 2024, then changed by 0.0% to $172200.0 in 2025.
- Per Business Quant, the three latest INM Raw Materials figures stand at $172200.0 (Q3 2025), $258300.0 (Q2 2025), and $258300.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 172,200.00 |
| Jun 30, 2025 | 258,300.00 |
| Mar 31, 2025 | 258,300.00 |
| Dec 31, 2024 | 172,200.00 |
| Sep 30, 2024 | 274,445.00 |
| Jun 30, 2024 | 372,695.00 |
| Mar 31, 2024 | 196,500.00 |
| Sep 30, 2023 | 208,737.00 |
| Jun 30, 2023 | 208,737.00 |
| Mar 31, 2023 | 387,071.00 |
| Dec 31, 2022 | 208,737.00 |
| Jun 30, 2022 | 292,577.00 |